Skip to main content
PMC home page
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2006 Oct 27;7(3):271–277. doi: 10.1111/j.1542-474X.2002.tb00174.x

The Multicenter Research Group

Arthur J Moss 1,✉, Robert E Goldstein 2, Henry Greenberg 3, Edward M Dwyer 4, J Thomas Bigger 5, Robert B Case 3; for the Multicenter Research Group[Link]
PMCID: PMC7027675  PMID: 12167190

The content is available as a PDF (648.1 KB).

REFERENCES

  • 1. Nathan DG. Clinical research: Perceptions, reality, and proposed solutions. JAMA 1998;280:1427–1431. [DOI] [PubMed] [Google Scholar]
  • 2. Campbell EG, Weissman JS, Moy E, et al. Status of clinical research in academic health centers: Views from the research leadership. JAMA 2001;286:800–806. [DOI] [PubMed] [Google Scholar]
  • 3. Nathan DG, Varmus HE. The National Institutes of Health and clinical research: A progress report. Nature Med 2000;6:1201–1204. [DOI] [PubMed] [Google Scholar]
  • 4. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309: 331–336. [DOI] [PubMed] [Google Scholar]
  • 5. Bigger JT Jr, Fleiss JL, Kleiger R, et al. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250–258. [DOI] [PubMed] [Google Scholar]
  • 6. Case RB, Heller SS, Case NB, et al. Type A behavior and survival after acute myocardial infarction. N Engl J Med 1985;312:737–741. [DOI] [PubMed] [Google Scholar]
  • 7. Kleiger RE, Miller JP, Bigger JT Jr., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–262. [DOI] [PubMed] [Google Scholar]
  • 8. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction.
  • 9. Case RB, Moss AJ, Case N. Living alone after myocardial infarction. Impact on prognosis. JAMA 1992;267: 515–519. [PubMed] [Google Scholar]
  • 10. Moss AJ, Goldstein RE, Hall WJ, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. JAMA 1993;269:2379–2385. [PubMed] [Google Scholar]
  • 11. Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999;99:2517–2522. [DOI] [PubMed] [Google Scholar]
  • 12. GISSI. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1: 397–401. [PubMed] [Google Scholar]
  • 13. Chesbero JH, Knattenud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76: 142–154. [DOI] [PubMed] [Google Scholar]
  • 14. Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and accountability. JAMA 2001;286:1232–1233. [DOI] [PubMed] [Google Scholar]
  • 15. Greenberg H, Gillespie J, Dwyer EM Jr, et al. A new electrocardiographic classification for postmyocardial infarction clinical trials. Am J Cardiol 1987;59:1057–1063. [DOI] [PubMed] [Google Scholar]
  • 16. Relman AS. Dealing with conflicts of interest. N Engl J Med 1984;310:1182–1183. [DOI] [PubMed] [Google Scholar]
  • 17. Healy B, Campeau L, Gray R, et al. Conflict of interest guidelines for multicenter clinical trial of treatment after coronary bypass graft surgery. N Engl J Med 1989;320:949–951. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES